IDRA · Categories · Form 4

IDRA - SEC Form 4 insider transactions

Idera Pharmaceuticals Inc. (IDRA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for IDRA

• 1033d
  SEC Form 4: Gowen Maxine sold $26 worth of shares (51 units at $0.51)

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1033d
  SEC Form 4: Milano Vincent sold $1,750 worth of shares (3,283 units at $0.53), decreasing direct ownership by 27% to 8,987 units

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1057d
  SEC Form 4 filed by Pillar Invest Corp

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1057d
  SEC Form 4 filed by Pillar Invest Corp

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1119d
  SEC Form 4 filed by Chopra Atul

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1119d
  SEC Form 4 filed by Chopra Atul

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1119d
  SEC Form 4 filed by Chopra Atul

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1223d
  SEC Form 4 filed by Kirby John J.

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1223d
  SEC Form 4 filed by Salain Daniel

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1223d
  SEC Form 4 filed by Jordan Andrew R

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1223d
  SEC Form 4 filed by Kraus Carl N

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1223d
  SEC Form 4 filed by Lim Bryant David

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1223d
  SEC Form 4 filed by Taylor John Clayton

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1237d
  SEC Form 4: Jordan Andrew R converted options into 402,529 shares, increasing direct ownership by 815% to 451,890 units

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1237d
  SEC Form 4 filed by Wooten Ronald J

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1237d
  SEC Form 4: Salain Daniel converted options into 1,341,764 shares, increasing direct ownership by 1,051% to 1,469,482 units

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1237d
  SEC Form 4 filed by Kraus Carl N

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1237d
  SEC Form 4: Taylor John Clayton converted options into 1,341,764 shares, increasing direct ownership by 1,051% to 1,469,482 units

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1238d
  SEC Form 4 filed by Novaquest Co-Investment Fund Xv, L.P.

  4 - Aceragen, Inc. (0000861838) (Issuer)
• 1244d
  SEC Form 4: Dougherty Michael R was granted 33,523 shares, increasing direct ownership by 10% to 375,155 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1246d
  SEC Form 4: Jordan Andrew R was granted 261,718 shares and covered exercise/tax liability with 73,940 shares, increasing direct ownership by 29% to 839,142 units to cover taxes

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1246d
  SEC Form 4: Lim Bryant David was granted 399,218 shares and covered exercise/tax liability with 119,957 shares, increasing direct ownership by 918% to 309,695 units (for tax liability)

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1246d
  SEC Form 4: Kirby John J. was granted 399,218 shares and covered exercise/tax liability with 119,957 shares, increasing direct ownership by 742% to 316,893 units (for withholding tax)

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1343d
  SEC Form 4: Dougherty Michael R was granted 58,516 shares, increasing direct ownership by 21% to 341,632 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1345d
  SEC Form 4: Novaquest Co-Investment Fund Xv, L.P. acquired 5 units of Series X Preferred Stock

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1348d
  SEC Form 4: Wooten Ronald J acquired 5 units of Series X Preferred Stock

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1348d
  SEC Form 4: Taylor John Clayton was granted 2,171,214 shares

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1348d
  SEC Form 4: Salain Daniel was granted 2,171,214 shares

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1348d
  SEC Form 4: Jordan Andrew R was granted 651,364 shares

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1348d
  SEC Form 4 filed by Kraus Carl N

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1352d
  SEC Form 4: Pillar Invest Corp exercised 1,533,159 in-the-money shares at a strike of $0.01

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1433d
  SEC Form 4 filed by Lim Bryant David

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1433d
  SEC Form 4 filed by Soland Daniel B

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1433d
  SEC Form 4 filed by Milano Vincent

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1433d
  SEC Form 4 filed by Kirby John J.

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1434d
  SEC Form 4: Dougherty Michael R was granted 50,086 shares, increasing direct ownership by 21% to 283,116 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1443d
  SEC Form 4 filed by Goldberg Mark Alan

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1443d
  SEC Form 4 filed by Gowen Maxine

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1443d
  SEC Form 4 filed by Dougherty Michael R

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1443d
  SEC Form 4 filed by Geraghty James A

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1443d
  SEC Form 4 filed by Schafer Carol

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1443d
  SEC Form 4 filed by Csimma Cristina

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1526d
  SEC Form 4: Dougherty Michael R was granted 41,155 shares, increasing direct ownership by 21% to 233,030 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1527d
  SEC Form 4 filed by Kirby John J.

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1527d
  SEC Form 4 filed by Lim Bryant David

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1527d
  SEC Form 4 filed by Soland Daniel B

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1527d
  SEC Form 4 filed by Milano Vincent

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1595d
  SEC Form 4 filed by Lim Bryant David

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1595d
  SEC Form 4 filed by Soland Daniel B

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1595d
  SEC Form 4 filed by Kirby John J.

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1595d
  SEC Form 4 filed by Milano Vincent

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1616d
  SEC Form 4: Dougherty Michael R was granted 37,062 shares, increasing direct ownership by 24% to 191,875 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1631d
  SEC Form 4: Kirby John J. bought $6,150 worth of shares (10,000 units at $0.61), increasing direct ownership by 36% to 37,632 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1709d
  SEC Form 4: Dougherty Michael R was granted 21,229 shares, increasing direct ownership by 16% to 154,813 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1794d
  SEC Form 4 filed by Kirby John J.

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1794d
  SEC Form 4 filed by Lim Bryant David

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1794d
  SEC Form 4 filed by SOLAND DANIEL B

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1794d
  SEC Form 4 filed by MILANO VINCENT

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1815d
  SEC Form 4: SOLAND DANIEL B bought $59,500 worth of Common Stock (50,000 units at $1.19), increasing direct ownership by 173% to 78,843 units

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)
• 1825d
  SEC Form 4 filed by GOWEN MAXINE

  4 - IDERA PHARMACEUTICALS, INC. (0000861838) (Issuer)

Other IDRA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends